Kangmei Pharma | 600518 - Sales Revenues



Kangmei Pharma reported CNY1.27B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Avita Medical AUD 18.41M 7.89M Dec/2024
Cspc Pharmaceutical CNY 7.01B 691.61M Mar/2025
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Genomma Lab Internacional MXN 4.68B 270M Jun/2025
Hypermarcas BRL 2.15B 1.07B Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Jiangsu Hengrui CNY 8.6B 1.39B Jun/2025
Kangmei Pharma CNY 1.27B 32.4M Jun/2025
Moderna USD 142M 34M Jun/2025
Organon & Co 1.59B 80M Jun/2025
Revvity USD 720M 55M Jun/2025
Sh Fosun Pharma CNY 10.01B 585.79M Jun/2025
Tectonic Therapeutic 0 0 Dec/2024
Viatris USD 3.57B 320M Jun/2025
Wuxi Apptec CNY 11.14B 1.75B Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 2.24B 902.99M Jun/2025